Distinct functions of dynamin isoforms in tumorigenesis and their potential as therapeutic targets in cancer
Metrics: PDF 1668 views | HTML 2672 views | ?
1 Charles Institute of Dermatology, School of Medicine and Medical Sciences, University College Dublin, Belfield, Dublin, Ireland
2 International Centre for Neurotherapeutics, Dublin City University, Glasnevin, Dublin, Ireland
Jianghui Meng, email:
Keywords: endocytosis, tumor, cancer target, clathrin, amphiphysin
Received: September 28, 2016 Accepted: March 09, 2017 Published: March 29, 2017
Dynamins and their related proteins participate in the regulation of neurotransmission, antigen presentation, receptor internalization, growth factor signalling, nutrient uptake, and pathogen infection. Recently, emerging findings have shown dynamin proteins can also contribute to the genesis of cancer. This up-to-date review herein focuses on the functionality of dynamin in cancer development. Dynamin 1 and 2 both enhance cancer cell proliferation, tumor invasion and metastasis, whereas dynamin 3 has tumor suppression role. Antisense RNAs encoded on the DNA strand opposite a dynamin gene regulate the function of dynamin, and manipulate oncogenes and tumor suppressor genes. Certain dynamin-related proteins are also upregulated in distinct cancer conditions, resulting in apoptotic resistance, cell migration and poor prognosis. Altogether, dynamins are potential biomarkers as well as representing promising novel therapeutic targets for cancer treatment. This study also summarizes the current available dynamin-targeted therapeutics and suggests the potential strategy based on signalling pathways involved, providing important information to aid the future development of novel cancer therapeutics by targeting these dynamin family members.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.